Amphastar Pharmaceuticals, Inc. (AMPH) Operating cash flow 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$156.1MFY2025 · since FY2016: $38.6M → $156.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $156.1M | -26.8% |
| FY2024 | $213.4M | +16.3% |
| FY2023 | $183.5M | +105.8% |
| FY2022 | $89.2M | -9.0% |
| FY2021 | $98.0M | +71.1% |
| FY2020 | $57.3M | +37.1% |
| FY2019 | $41.8M | +9.4% |
| FY2018 | $38.2M | -2.6% |
| FY2017 | $39.2M | +1.7% |
| FY2016 | $38.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net incomeAMPH Net marginAMPH Gross profitAMPH Gross marginAMPH Operating incomeAMPH Operating marginAMPH Free cash flowAMPH Capital expendituresAMPH Return on equityAMPH Stock buybacksAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →